Identification of a novel vasoconstrictor peptide specific for the systemic circulation

Hypertension

Volumn 59, Issue 6, 2012, Pages 1256-1262

  Wenzel, Daniela ^a   Koch, Manuel ^b   Matthey, Michaela ^a   Heinemann, Jan C ^a   Fleischmann, Bernd K ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cell signaling; Ion channels; Peptides; Smooth muscle; Vasoconstriction

Indexed keywords

CALCIUM CHANNEL L TYPE; CATION CHANNEL; LAMININ NONAPEPTIDE; NONAPEPTIDE; NONSELECTIVE CATION CHANNEL; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CALCIUM TRANSPORT; CONTROLLED STUDY; HUMAN; LUNG PERFUSION; MAMMARY ARTERY; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PULMONARY ARTERY; SYSTEMIC CIRCULATION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

AMINO ACID SEQUENCE; ANIMALS; ARTERIES; BLOOD CIRCULATION; BLOOD PRESSURE; CALCIUM; CALCIUM CHANNELS; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LAMININ; MALE; MAMMARY ARTERIES; MEMBRANE POTENTIALS; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; TAIL; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84861531565     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.188367     Document Type: Article

References (26)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Page IH, Helmer Om. A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator. J Exp Med. 1940;71:29-42.
3. Hahn AW, Resink TJ, Kern F, Buhler FR. Peptide vasoconstrictors, vessel structure, and vascular smooth-muscle proliferation. J Cardiovasc Pharmacol. 1993;22:S37-S43.
4. Sakamoto N, Iwahana M, Tanaka NG, Osada Y. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. Cancer Res. 1991;51:903-906.
5. Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, Kleinman HK. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry. 1987;26: 6896-6900.
6. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science. 1987;238:1132-1134.
7. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell. 1989;58: 933-943.
8. Gloe T, Riedmayr S, Sohn HY, Pohl U. The 67-kDa laminin-binding protein is involved in shear stress-dependent endothelial nitric-oxide synthase expression. J Biol Chem. 1999;274:15996-16002.
9. Wang YG, Samarel AM, Lipsius SL. Laminin acts viä1 integrin signalling to alter cholinergic regulation of l-type Ca(2) current in cat atrial myocytes. J Physiol. 2000;526:57-68.
10. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev. 2005;85:979-1000.
11. Pietschmann P, Schernthaner G, Schnack CH, Gaube S. Serum concentrations of laminin P1 in diabetics with advanced nephropathy. J Clin Pathol. 1988;41:929-932.
12. Faury G, Garnier S, Weiss AS, Wallach J, Fulop T Jr, Jacob MP, Mecham RP, Robert L, Verdetti J. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2level in human vascular endothelial cells. Circ Res. 1998;82:328-336.
13. Wenzel D, Schmidt A, Reimann K, Hescheler J, Pfitzer G, Bloch W, Fleischmann BK. Endostatin, the proteolytic fragment of collagen XVIII, induces vasorelaxation. Circ Res. 2006;98:1203-1211.
14. Saleh SN, Albert AP, Peppiatt CM, Large WA. Angiotensin II activates two cation conductances with distinct TRPC1 and TRPC6 channel properties in rabbit mesenteric artery myocytes. J Physiol. 2006;577:479-495.
15. Maruyama Y, Nakanishi Y, Walsh EJ, Wilson DP, Welsh DG, Cole WC. Heteromultimeric TRPC6-TRPC7 channels contribute to arginine vasopressin-induced cation current of A7r5 vascular smooth muscle cells. Circ Res. 2006;98:1520-1527.
16. Dietrich A, Mederos YS, Gollasch M, Gross V, Storch U, Dubrovska G, Obst M, Yildirim E, Salanova B, Kalwa H, Essin K, Pinkenburg O, Luft FC, Gudermann T, Birnbaumer L. Increased vascular smooth muscle contractility in TRPC6/mice. Mol Cell Biol. 2005;25:6980-6989.
17. Hein TW, Platts SH, Waitkus-Edwards KR, Kuo L, Mousa SA, Meininger GA. Integrin-binding peptides containing RGD produce coronary arteriolar dilation via cyclooxygenase activation. Am J Physiol Heart Circ Physiol. 2001;281:H2378-H2384.
18. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell. 1987;48: 989-996.
19. Castronovo V, Taraboletti G, Sobel ME. Functional domains of the 67-kDa laminin receptor precursor. J Biol Chem. 1991;266:20440-20446.
20. Terasawa K, Nakajima T, Iida H, Iwasawa K, Oonuma H, Jo T, Morita T, Nakamura F, Fujimori Y, Toyo-oka T, Nagai R. Nonselective cation currents regulate membrane potential of rabbit coronary arterial cell: modulation by lysophosphatidylcholine. Circulation. 2002;106: 3111-3119.
21. Nakajima T, Hazama H, Hamada E, Wu SN, Igarashi K, Yamashita T, Seyama Y, Omata M, Kurachi Y. Endothelin-1 and vasopressin activate Ca(2)-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptor-mediated Ca2influx. J Mol Cell Cardiol. 1996;28:707-722.
22. Callaghan B, Koh SD, Keef KD. Muscarinic M2 receptor stimulation of Cav1.2b requires phosphatidylinositol 3-kinase, protein kinase C, and c-Src. Circ Res. 2004;94:626-633.
23. Cobine CA, Callaghan BP, Keef KD. Role of l-type calcium channels and PKC in active tone development in rabbit coronary artery. Am J Physiol Heart Circ Physiol. 2007;292:H3079-H3088.
24. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med. 2006;34:1126-1130.
25. Watson A. Adrenergic blockers and adrenaline: a mysterious collapse. Aust Fam Physician. 1998;27:714-715.
26. Walker BR, Haynes J Jr, Wang HL, Voelkel NF. Vasopressin-induced pulmonary vasodilation in rats. Am J Physiol. 1989;257:H415-H422.